04/24/2026
If genetic testing could determine which cancer therapy is most effective for a patient, shouldn’t it be covered?
This , Episode 58 of Unscripted tackles precision medicine and clinical utility in cancer care. Dr. John Fox (Illumina) and Steve Kheloussi (Principal Consultant with Kheloussi Consulting) break down lab-developed tests vs. FDA companion diagnostics, payer decision-making, and preventable deaths in lung cancer.
Plus: one question pharmacists can ask during prior auth that actually changes outcomes.
Listen now: https://hubs.li/Q04dq7Zp0